期刊文献+

影像组学预测肝细胞癌微血管侵犯的研究现状

Research Status of Radiomics for Predicting Microvascular Invasion in Hepatocellular Carcinoma
下载PDF
导出
摘要 肝细胞癌(HCC)是目前对人类健康造成巨大威胁的常见恶性肿瘤之一,由于其发病率、死亡率都很高以及预后不理想,对于肝细胞癌的治疗一直都是我们需要攻克的难题。微血管侵犯(MVI)已经被多项研究证实是肝细胞癌术后复发以及预后不良的重要原因。然而,MVI的诊断主要是在术后通过肝细胞癌的病理学检查来确诊。如果能在术前对MVI进行一定的预测,将会对指导个体化治疗方案以及提高患者的预后产生巨大的影响。现阶段已有不少的研究利用CT或MRI影像组学的方法对HCC MVI进行预测,并且都取得了很好的效果。本文将对目前关于HCC MVI影像组学预测的研究进展进行阐述。 Hepatocellular carcinoma(HCC)is one of the most common malignant tumors that pose a great threat to human health,and its treatment has always been a challenge due to its high morbidity and mortality rates and poor prognosis.Microvascular invasion(MVI)has been shown to be an important cause of postoperative recurrence and poor prognosis in hepatocellular carcinoma in several studies.However,the diagnosis of MVI is mainly confirmed by histopathologic examination of hepatocellular carcinoma after surgery.If MVI could be predicted before surgery,it would have a great impact on guiding individualized treatment plans and improving patients'prognosis.At this stage,many studies have been conducted on the prediction of HCC MVI using CT or MRI radiomics,and all of them have achieved very good results.In this paper,we will describe the current research progress on the radiomic prediction of HCC MVI.
作者 罗家佳 李倩 杜勇 LUO Jia-jia;LI Qian;DU Yong(Department of Radiology,Affiliated Hospital of North Sichuan Medical College,Nanchong637000,Sichuan Province,China;Department of Radiology,Second People's Hospital of Yibin,Yibin 644000,Sichuan Province,China)
出处 《中国CT和MRI杂志》 2024年第2期176-178,共3页 Chinese Journal of CT and MRI
基金 国家临床重点专科建设项目([2023]No.87)。
关键词 肝细胞癌 微血管侵犯 磁共振成像 计算机断层成像 影像组学 Hepatocellular Carcinoma Microvascular Invasion Magnetic Resonance Imaging Computed Tomography Radiomics
  • 相关文献

参考文献8

二级参考文献63

  • 1Wan-Yee Lau,Eric C. H. Lai.Hepatocellular carcinoma: current management and recent advances[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):237-257. 被引量:101
  • 2Llovet JM,Burroughs A,Bruix J.Hepatocellular carcinomaThe Lancet,2003.
  • 3Lai EC;You KT;Ng IO.The pathological basis of resection margin for hepatocellular carcinoma,1993(06).
  • 4Malcolm R. Alison.Liver stem cells[J]. Stem Cell Reviews . 2005 (3)
  • 5Peng SY,Chen WJ,Lai PL,Jeng YM,Sheu JC,Hsu HC.High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. International Journal of Cancer . 2004
  • 6Uenishi T,Kubo S,Yamamoto T,Shuto T,Ogawa M,Tanaka H,Tanaka S,Kaneda K,Hirohashi K.Cytokeratin19expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Science . 2003
  • 7Llovet JM,Schwartz M,Mazzaferro V.Resection and liver transplantation for hepatocellular carcinoma. Seminars in Liver Disease . 2005
  • 8Edmondson HA,Steiner PE.Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer . 1954
  • 9Harris C C.Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. Journal of the National Cancer Institute . 1996
  • 10Poon R T,Fan S T,Ng I O,et al.Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer . 2000

共引文献312

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部